Evidence map›Paper›PMID 38982261›Full record

ArticleLeukemia2024

Myelofibrosis management in routine clinical practice with a focus on patients with cytopenias: recommendations from a global consensus group.

Steffen Koschmieder, Prithviraj Bose, Martin H Ellis, Vikas Gupta, Jean-Jacques Kiladjian, John Mascarenhas, Vikram Mathews, Francesco Passamonti, Claire Harrison

Abstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Secondary Neutropenias.Biomedicines · 2025
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Steffen KoschmiederDepartment of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany.ORCID 0000-0002-1011-8171
Prithviraj BoseThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-4343-5712
Martin H EllisHematology Institute and Blood Bank, Meir Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0001-6804-1472
Vikas GuptaPrincess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.ORCID 0000-0002-1419-8607
Jean-Jacques KiladjianHôpital Saint-Louis, Université Paris Cité, Inserm CIC-1427, Paris, France.
John MascarenhasTisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-8400-0483
Vikram MathewsDepartment of Haematology, Christian Medical College, Vellore, Tamil Nadu, India.ORCID 0000-0001-9417-2353
Francesco PassamontiUniversità degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
Claire HarrisonDepartment of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK. Claire.Harrison@gstt.nhs.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Primary MyelofibrosisCytopeniaDisease ManagementHumansThrombocytopenia

Identifiers

PMID38982261
PMCPMC11286526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.